Cancer immunotherapy is changing what survival looks like, but the price can stop patients before treatment even starts. In the United States a full course can climb toward $45,000, and in the UK private care runs higher still. Abroad the math changes sharply: in Turkey the same treatment starts around $2,200, with savings of up to 85% against the US baseline at hospitals accredited by JCI. Bookimed helps patients compare verified clinics, doctors, and transparent prices across countries. This guide breaks down what immunotherapy actually costs around the world, why the numbers vary so much, and where the price is heading next.
Key Takeaways: Immunotherapy Costs
Cost savings:
Immunotherapy abroad is up to 85% cheaper than in the U.S. and U.K.
Turkey: $2,200â$5,400
Thailand: $20,000â$40,000
Germany: from $3,500
Israel: $2,400â$4,900
Mexico: $8,000â$16,000
Top destinations:
Affordable all-inclusive packages (hotel, transfers, coordinator).
JCI-accredited hospitals with extended care.
Table of Contents:
- Key Takeaways: Immunotherapy Costs
- Â
- What Is Immunotherapy For Cancer?
- Immunotherapy Cost Around the World
- All-Inclusive Immunologic Therapy Packages
- Why Does Immunotherapy Cost Vary So Much?
- Chemotherapy vs Immunotherapy Cost Comparison
- When Will Immunotherapy Get Cheaper? Biosimilars Coming by 2028
- Top Destination: Immunotherapy in Turkey vs. Thailand
- Insurance Coverage and Travel Safety for Immunotherapy Abroad
- FAQ: Immunotherapy Cost Abroad
- Begin Your Immunotherapy Journey with Bookimed
What Is Immunotherapy For Cancer?
Immunotherapy is a medical treatment that helps the body's immune system recognize and fight cancer. Instead of directly attacking cancer cells like chemotherapy or radiation, immunotherapy teaches the immune system how to find and destroy them.
To explain it simply, imagine the body as a kingdom. The immune system is its army, always on guard against threats like viruses, bacteria, and other intruders. But cancer is a clever enemy, wearing disguises and blending in with healthy cells. The army doesn't always see it as a threat.
Immunotherapy gives the immune system new tools, training, or instructions so it can finally recognize the disguised cancer cells and target them precisely.
There are several main types
| Type | Description |
|---|---|
| Checkpoint inhibitors | Medications that remove the brakes from immune cells, allowing them to attack cancer more effectively. |
| CAR-T cell therapy | Doctors take a patient's immune cells, genetically reprogram them to target cancer, and return them to the body. |
| Cancer vaccines | Teach the immune system to recognize and attack cancer cells. |
| Cancer treatment vaccines | These vaccines aim to treat existing cancer by stimulating the immune system to attack cancer cells. |
| Monoclonal antibodies | Lab-created proteins that stick to cancer cells and flag them for attack. |
A 10-year trial confirms the long-term power of immune therapy. In 945 patients across 21 countries, combining nivolumab and ipilimumab immune checkpoint inhibitors significantly improved survival in advanced melanoma. With effects lasting beyond 6.5 years for many, this study shows that immunotherapy can transform once-fatal cancers into manageable conditions.
Often, these treatments are used in combination with other therapies, known as treatment combinations, to enhance their effectiveness.
Conditions treated by immunotherapy
Immunotherapy is especially effective for advanced, hard-to-treat cancers or those that haven't responded to traditional treatments.
| Cancer Type | Common Immunotherapy |
|---|---|
| Non-small cell lung cancer | PD-1/PD-L1 inhibitors |
| Small cell lung cancer | Immunotherapy combined with chemotherapy |
| Triple-negative breast cancer | Atezolizumab plus chemotherapy |
| Melanoma | Checkpoint inhibitors |
| Blood cancers (e.g., lymphoma) | CAR-T cell therapy |
| Bladder, liver, prostate | Experimental or newly approved therapies |
Since the introduction of immune-system therapy in 2015, survival for patients with advanced non-small cell lung cancer (NSCLC), the most common type of lung cancer, has significantly improved. In a study of over 190,000 patients, 5-year survival nearly doubled from 6.8% to 10.7%. These results show that immunotherapy is making a real, measurable impact on lung cancer treatment.
The field is still moving fast. In 2024 the FDA approved the first tumor-infiltrating lymphocyte (TIL) therapy, lifileucel (Amtagvi), and the first TCR-engineered T-cell therapy for a solid tumor, while researchers advance "off-the-shelf" CAR-T designed to shorten the weeks-long cell-manufacturing wait. For patients, these recent approvals matter because they widen the range of cancers immunotherapy can treat and speed up access to personalized options.
Immunotherapy Cost Around the World
Immunotherapy prices swing widely from one country to the next. The same checkpoint inhibitor or monoclonal antibody can cost several times more in one health system than another, driven by patented drug pricing, hospital and service fees, and local healthcare economics. The table below compares typical immunotherapy costs across Bookimed-network destinations, with the United States and United Kingdom shown as reference baselines.
| Country | Lung cancer | Melanoma | Breast cancer (TNBC) | Blood cancers (CAR-T) | Other solid tumors |
|---|---|---|---|---|---|
| Germany | $50,000â$100,000 | from $3,500 | $22,000â$38,000 | $350,000â$500,000 | $28,000â$35,000 |
| Israel | $22,000â$28,000 | $2,400â$4,900 | $22,000â$28,000 | $72,000â$112,800 | $20,000â$28,000 |
| Mexico | $22,000â$38,000 | $8,000â$16,000 | $30,000â$60,000 | $250,000â$400,000 | $12,000â$18,000 |
| Turkey | $18,000â$28,000 | $2,200â$5,400 | $9,500â$17,500 | $150,000â$225,000 | $10,000â$13,000 |
| Thailand | $25,000â$45,000 | $20,000â$40,000 | $15,000â$25,000 | $250,000â$350,000 | $8,000â$12,000 |
| Belarus | $8,000â$10,000 | $9,000â$11,000 | $8,000â$10,000 | $55,000â$65,000 | $7,000â$10,000 |
| Republic of Korea | $22,000â$28,000 | $4,500â$8,500 | $22,000â$28,000 | $385,000â$515,000 | $20,000â$28,000 |
| Spain | $30,000â$60,000 | $12,000â$25,000 | $45,000â$95,000 | $330,000â$420,000 | $4,100â$6,400 |
| United Kingdom | $60,000â$100,000 | $60,000â$100,000 | $60,000â$90,000 | $350,000â$500,000 | $20,000â$28,000 |
For patients starting from the US or UK figures, destinations like Turkey and Israel represent savings of up to 85% against the US baseline. The US and UK rows are included only as price references; Bookimed coordinates treatment in its network destinations rather than routing patients to those markets. Cross-country drug-pricing differences like these are well documented in European health-economics research.
All-Inclusive Immunologic Therapy Packages
Many clinics abroad offer all-inclusive immunotherapy packages that combine treatment with travel services, making care more straightforward and more affordable.
A typical package may include:
Immunotherapy sessions (e.g., Keytruda, CAR-T).
Doctor consultations and diagnostic tests.
Hospital stay or hotel accommodation.
Airport-clinic transfers.
24/7 support and a personal medical coordinator.
These all-inclusive packages often cost less than booking each service separately, making them a practical choice for patients who want high-quality treatment at a more manageable price.
Our top offers
- Dr. Ari Raphael has significantly contributed to clinical research, enhancing patient enrollment in clinical trials.
- Sourasky Medical Center (Ichilov) treats over 400,000 patients annually, ranking among the top 10 for medical tourists.
- Included Services: Hospitalization, Transfer to the hospital.
- Stay Info: 1 day stay in the hospital, 1 day stay in the hotel.
- Treatment Method: KADCYLA for treating HER2+ early breast cancer or HER2+ metastatic breast cancer.
- Einat Shacham Shmueli is a senior oncologist specializing in advanced gastrointestinal cancer management and research.
- Sheba Medical Center treats over 2 million patients annually and is a global leader in precision oncology.
- Included Services: Blood tests.
- Stay Info: 12 days hotel stay; accommodation is not included in the price.
- Dr. Joan Carles Galceran achieved prominence in bladder cancer treatment through advanced oncological techniques.
- Centro MĂ©dico Teknon is the No.1 choice for celebrities, sportsmen, and politicians for medical care.
- Included Services: Complete blood count with cancer markers, proteinogram.
- Stay Info: 1-day stay in the hotel, accommodation not included in the price.
- Method: Keytruda (1 injection, 200 mg).
Why Does Immunotherapy Cost Vary So Much?
The cost of immunotherapy for cancer can differ by tens or even hundreds of thousands of dollars depending on where it's received. Here are the main factors that explain the price gap.
Local healthcare pricing
In countries with public healthcare systems, like Spain or Israel, governments negotiate drug prices and offer subsidies, bringing the cost far below U.S. rates. In contrast, U.S. patients often face full market prices.
Patented drugs and biosimilars
A large share of the price sits in the drug itself. Patented biologic medicines in high-income countries like the U.S. drive costs upward, while markets that already use biosimilars, lower-cost versions of original biological drugs, pay significantly less. This patent dynamic is also why prices are expected to fall later this decade, as we cover in the biosimilars section below.
Hospital and service fees
The immunotherapy cost per treatment also includes consultations, scans, and infusions. In the U.S., hospital fees can triple the total cost compared to clinics in Turkey or Mexico. Organizations like the World Health Organization (WHO) note significant disparities in treatment costs across regions.
Access to support programs
Governments, charities, or manufacturers sometimes offer assistance. For example, Cancer Research UK and the National Cancer Institute (NCI) provide resources on programs that may help reduce immunotherapy costs or help patients join clinical trials.
Patients can also seek financial support from various programs to help manage the high costs of immunotherapy.
Chemotherapy vs Immunotherapy Cost Comparison
When patients weigh treatment options, cost is often part of the conversation alongside effectiveness. As a rule, chemotherapy tends to cost less per cycle than immunotherapy. Many chemotherapy regimens rely on long-established generic drugs that are inexpensive to produce, while immunotherapy depends on patented biologic medicines, such as checkpoint inhibitors and monoclonal antibodies, that carry a much higher price.
That said, a simple per-cycle comparison rarely tells the whole story. Total cost depends on the cancer type, how long the regimen runs, and whether immunotherapy is given on its own or combined with chemotherapy. Some patients receive a short course of immunotherapy with durable results, while others need extended treatment that adds up over time. Differences in patented-drug pricing between countries, documented in European health-economics research, also shift the balance depending on where care is delivered. The right choice is a clinical decision made with your oncologist; the cost difference is one factor among several, not the deciding one.
When Will Immunotherapy Get Cheaper? Biosimilars Coming by 2028
One reason immunotherapy stays expensive is that the biggest drugs are still protected by patents. Without competition, manufacturers set the price. That picture is about to change. Patents on the two best-known checkpoint inhibitors, pembrolizumab (Keytruda) and nivolumab (Opdivo), are scheduled to expire between 2028 and 2033, opening the door to biosimilars, which are highly similar, lower-cost versions of biologic drugs.
The pipeline is already moving. Drugmakers including Samsung Bioepis, Amgen, and Celltrion are running Phase 3 biosimilar trials aimed at these immunotherapy targets, positioning their products to launch as the patents lapse. When biosimilars reach the market, they typically force prices down: across other biologic categories, biosimilar competition has cut prices by roughly 20% to 40%, according to European drug-pricing research. Tracking which new therapies and approvals are emerging is easier with resources like the 2024â2025 immunotherapy approvals guide.
For patients planning long-horizon treatment, timing matters. If your care can be staged over the coming years, biosimilars may bring meaningful savings. It is worth asking clinics whether a biosimilar option is available or expected for your specific drug, and factoring that into both budget and treatment planning.
Top Destination: Immunotherapy in Turkey vs. Thailand
With dozens of countries offering cancer care abroad, Turkey and Thailand stand out as top destinations for affordable, high-quality biological therapy.
Turkey
Turkey attracts over 1.5 million medical tourists annually, with cancer treatment among the most in-demand services. Immunotherapy here starts around $2,200 and runs to about $5,400 at internationally accredited clinics built for foreign patients.
Pros
Lower cost. Biological therapy starts at $2,200, including diagnostics and drugs like Keytruda.
All-inclusive packages. Often include hotels, airport-clinic transfers, and personal coordinators.
Shorter treatment time. Efficient pre-checks and treatment allow stays as short as 7 to 10 days.
No visa hassle. Visa-free or easy e-visa for most countries.
English-speaking staff: common in private clinics serving international patients.
Cons
Follow-up may be remote: post-treatment monitoring often happens via telemedicine.
Explore the best clinics in Turkey
Thailand
Thailand is known for its JCI-accredited hospitals, which meet international standards in safety and quality.
Pros
Top-tier hospital care. Treatments are often provided in facilities certified by global bodies like TEMOS International or QHA Trent Accreditation, all of which ensure strict standards for patient safety.
English is widely spoken. Medical teams routinely treat international patients.
Extended care. Programs include longer observation and personalized recovery plans (2 to 4 weeks).
Comfortable recovery environment. Patients rest in a warm climate.
Cons
Visa may be required: though usually easy to obtain, some nationalities need a visa.
Explore the best clinics in Thailand
Insurance Coverage and Travel Safety for Immunotherapy Abroad
When patients travel abroad for cancer care, they often ask: how much does immunotherapy for cancer cost with insurance, and will their plan help cover the expenses?
Domestic insurance (like Medicare or NHS) usually does not cover treatment outside the home country, especially if it is not emergency care. Patients heading to Turkey, Thailand, Mexico, or Israel for immunotherapy typically pay out-of-pocket.
Still, with costs up to 85% lower than in the U.S., treatment abroad may remain the more affordable option, even without coverage.
What's covered (with the right plan)?
Some international insurers partially or fully cover immunotherapy abroad, depending on the policy. These plans may reimburse immunotherapy when it is pre-approved and carried out at authorized clinics.
These policies often require pre-authorization, medical records, and treatment at approved facilities.
What's usually not covered?
Exceptions are rare and usually limited to urgent care or special EU cross-border agreements.
How to prepare?
Patients seeking treatment abroad should:
Check if their policy includes international oncology coverage.
Get pre-approval and clarify reimbursement options.
Request a full medical bill from the foreign clinic.
Explore aid programs and clinical trials if coverage is denied.
In summary, most travelers will need to self-fund their treatment abroad. But thanks to significantly lower prices in medical tourism hubs, the cost of immunotherapy for cancer may still be far more manageable than at home, even without insurance.
Is it safe to travel during treatment?
Travel itself needs planning. Because immunotherapy can suppress the immune system, flying raises infection-exposure risk, and long flights add cabin-pressure and clot considerations, so clear any trip with your oncologist and try to time flights around treatment cycles rather than immediately after an infusion. When choosing where to go, treat JCI accreditation as a meaningful safety signal: it shows a hospital meets international standards for patient safety, but it is not a guarantee of lower price or of any particular outcome. Pair it with verified reviews and a clear treatment plan before you commit.
FAQ: Immunotherapy Cost Abroad
How much does immunotherapy cost in Turkey?
At Bookimed-network hospitals, immunotherapy in Turkey starts around $2,200 and runs to about $5,400, depending on the drug and treatment plan. That is a fraction of the $15,000 to $45,000 typical in the United States, while care is delivered at JCI-accredited hospitals.
What is the cost of Keytruda (pembrolizumab) treatment abroad?
Keytruda costs depend on the number of cycles, your weight-based dosing, and the country. Abroad, pembrolizumab-based treatment generally runs well below US list prices. Because dosing varies per patient, ask the clinic for a per-cycle quote rather than relying on a single headline figure.
Does insurance cover immunotherapy treatment abroad?
Sometimes. Coverage depends entirely on your plan, and many insurers require pre-authorization plus detailed medical documentation before they will reimburse care received overseas. Confirm the specifics in writing with your provider before you travel, and keep all invoices and treatment records.
Is it safe to fly during immunotherapy treatment?
Clear any travel with your oncologist first. Immunotherapy can suppress the immune system, so flying raises infection-exposure risk, and long flights add cabin-pressure and clot considerations. Many patients can travel safely by timing flights around treatment cycles and following their care team's precautions.
What is the difference between chemotherapy and immunotherapy cost?
Chemotherapy is usually cheaper per cycle because it often uses long-established generic drugs, while immunotherapy relies on costly patented biologics. Total cost still depends on cancer type, regimen length, and whether the two are combined.
When will immunotherapy become cheaper with biosimilars?
Patents on Keytruda and Opdivo expire between 2028 and 2033, opening the door to biosimilars from makers like Samsung Bioepis, Amgen, and Celltrion. As those lower-cost versions reach the market, immunotherapy prices are expected to fall.
How do I find a JCI-accredited hospital for immunotherapy abroad?
Check the JCI accredited-facility directory and confirm the hospital runs an oncology or immunotherapy program. Bookimed lists verified JCI-accredited options and coordinates introductions, so you can compare credentials before you commit.
Begin Your Immunotherapy Journey with Bookimed
Bookimed makes accessing affordable immunotherapy for cancer abroad simple and convenient. Here's how to start your immunotherapy journey:
Browse immuno-oncology treatment options â explore a variety of treatments and find the best options tailored to your condition and budget.
Submit an inquiry â fill out a simple form detailing your diagnosis, the type of cancer, and any specific preferences for treatment.
Get expert advice â our medical coordinators will help you choose the best clinic for immuno-oncology treatment abroad based on your needs, desired outcomes, and financial situation.
Confirm and book â once you've selected the right clinic, we'll manage all the details, ensuring a smooth process.
Travel arrangements â we assist with flights, accommodation, local transfers, and resolving any unforeseen issues.
Full support â enjoy 24/7 support from your dedicated Bookimed coordinator throughout your stay and treatment journey abroad.
Feel free to read immunotherapy treatment reviews on Bookimed. Patient reviews help future patients understand the effectiveness, risks, and real experiences of treatment.
All medical content on this page is prepared by authors with specialized medical education and reviewed by certified physicians in the relevant field. Medical review by Yesim Yildirim, Clinical oncologist.
Last updated: June, 2026.
- Statistics: Figures are based on Bookimedâs internal database June 2026, which includes analysis of 12,450 patient requests across accredited clinics in .
- Pricing: Cost information is provided directly by Bookimedâs partner clinics and updated regularly to reflect current 2026 market conditions. Actual expenses may differ depending on case complexity, surgeon expertise, and clinic location.
- Clinical Data: Treatment outcomes and patient satisfaction figures are collected from Bookimedâs verified clinic database and supported by data from peer-reviewed medical sources such as PubMed, The Lancet, JAMA, and NEJM (2023â2026).
All data is provided for general informational purposes and may not represent individual results or experiences.